Lonza
NeuroSense, Lonza Partner to Identify Exosome-Based Neurodegenerative Disease Biomarkers
The collaboration will initially support further development of NeuroSense's lead amyotrophic lateral sclerosis drug candidate, PrimeC.
Oxford Nanopore Technologies, Lonza to Develop mRNA Quality Control Test
The collaboration aims to commercialize a current good manufacturing practice (cGMP)-validated test to analyze several quality attributes of mRNA products.
Arbor Biotechnologies Licenses Gene Editing Tech to Lonza
Basel, Switzerland-based Lonza will be able to use Arbor's proprietary CRISPR technology in its bioproduction products and services.
In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More
News items for the week of June 8, 2020.
Dec 13, 2018
ERS Genomics Licenses CRISPR Tech to Lonza
May 30, 2017
May 16, 2017
Lonza Acquires HansaBioMed, Invests in Exosomics
Apr 14, 2011
Apr 11, 2011
Roche, Lonza to Co-distribute MycoTool Test
Oct 28, 2010
Feb 3, 2010
Lonza, Bar Harbor Biotech Expand Pact
Jan 21, 2010